Genetic–epigenetic interaction modulates µ-opioid receptor regulation
Authors:
Open Access
- 8 August 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 21 (21) , 4751-4760
Abstract
Genetic and epigenetic mechanisms play important roles in protein expression, although at different levels. Genetic variations can alter CpG sites and thus influence the epigenetic regulation of mRNA expression, providing an increasingly recognized mechanism of functional consequences of genetic polymorphisms. One of those genetic effects is the association of reduced μ-opioid receptor expression with the functional genetic variant N40D (OPRM1 118A>G, rs1799971) that causes an amino acid exchange in the extracellular terminal of the μ-opioid receptor. We report that the nucleotide exchange at gene position +118 introduces a new CpG-methylation site into the OPRM1 DNA at position +117. This leads to an enhanced methylation of the OPRM1 DNA at this site and downstream. This epigenetic mechanism impedes μ-opioid receptor upregulation in brain tissue of Caucasian chronic opiate addicts, assessed postmortem. While in wild-type subjects, a reduced signalling efficiency associated with chronic heroin exposure was compensated by an increased receptor density, this upregulation was absent in carriers of the 118G receptor variant due to a diminished OPRM1 mRNA transcription. Thus, the OPRM1 118A>G SNP variant not only reduces µ-opioid receptor signalling efficiency, but, by a genetic–epigenetic interaction, reduces opioid receptor expression and therefore, depletes the opioid system of a compensatory reaction to chronic exposure. This demonstrates that a change in the genotype can cause a change in the epigenotype with major functional consequences.Keywords
This publication has 49 references indexed in Scilit:
- Abundant Quantitative Trait Loci Exist for DNA Methylation and Gene Expression in Human BrainPLOS Genetics, 2010
- Genetic Control of Individual Differences in Gene-Specific Methylation in Human BrainThe American Journal of Human Genetics, 2010
- Differential Opioid Action on Sensory and Affective Cerebral Pain ProcessingClinical Pharmacology & Therapeutics, 2007
- Perceptions of epigeneticsNature, 2007
- The μ-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriersPharmacogenetics and Genomics, 2006
- Are μ-opioid receptor polymorphisms important for clinical opioid therapy?Trends in Molecular Medicine, 2005
- Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroinHuman Mutation, 2002
- The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphinePharmacogenetics, 2002
- Association between mu opioid receptor gene polymorphisms and Chinese heroin addictsNeuroReport, 2001
- Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addictionProceedings of the National Academy of Sciences, 1998